Evidence map›Paper›PMID 34147122›Full record

ArticleBiotechnology for biofuels2021

Modular biosynthesis of plant hemicellulose and its impact on yeast cells.

Madalen Robert, Julian Waldhauer, Fabian Stritt, Bo Yang, Markus Pauly, Cătălin Voiniciuc

Open access · goldAbstract read
In one paragraph

Article in Biotechnology for biofuels, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Synthesis of Plant-InspiredACS synthetic biology · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Glucomannan inGenes · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Madalen RobertIndependent Junior Research Group - Designer Glycans, Leibniz Institute of Plant Biochemistry, 06120, Halle, Germany.
Julian WaldhauerIndependent Junior Research Group - Designer Glycans, Leibniz Institute of Plant Biochemistry, 06120, Halle, Germany.
Fabian StrittInstitute for Plant Cell Biology and Biotechnology, Heinrich Heine University, 40225, Düsseldorf, Germany.
Bo YangIndependent Junior Research Group - Designer Glycans, Leibniz Institute of Plant Biochemistry, 06120, Halle, Germany.
Markus PaulyInstitute for Plant Cell Biology and Biotechnology, Heinrich Heine University, 40225, Düsseldorf, Germany.
Cătălin VoiniciucIndependent Junior Research Group - Designer Glycans, Leibniz Institute of Plant Biochemistry, 06120, Halle, Germany. catalin.voiniciuc@ipb-halle.de.ORCID http://orcid.org/0000-0001-9105-014X
Leibniz Institute of Plant Biochemistry · DEHeinrich Heine University Düsseldorf · DE

Funding

Deutsche Forschungsgemeinschaft 414353267Deutsche Forschungsgemeinschaft EXC 2048/1-Project ID: 390686111
6 · The paper itself

Abstract

backgroundThe carbohydrate polymers that encapsulate plants cells have benefited humans for centuries and have valuable biotechnological uses. In the past 5 years, exciting possibilities have emerged in the engineering of polysaccharide-based biomaterials. Despite impressive advances on bacterial cellulose-based hydrogels, comparatively little is known about how plant hemicelluloses can be reconstituted and modulated in cells suitable for biotechnological purposes.

resultsHere, we assembled cellulose synthase-like A (CSLA) enzymes using an optimized Pichia pastoris platform to produce tunable heteromannan (HM) polysaccharides in yeast. By swapping the domains of plant mannan and glucomannan synthases, we engineered chimeric CSLA proteins that made β-1,4-linked mannan in quantities surpassing those of the native enzymes while minimizing the burden on yeast growth. Prolonged expression of a glucomannan synthase from Amorphophallus konjac was toxic to yeast cells: reducing biomass accumulation and ultimately leading to compromised cell viability. However, an engineered glucomannan synthase as well as CSLA pure mannan synthases and a CSLC glucan synthase did not inhibit growth. Interestingly, Pichia cell size could be increased or decreased depending on the composition of the CSLA protein sequence. HM yield and glucose incorporation could be further increased by co-expressing chimeric CSLA proteins with a MANNAN-SYNTHESIS-RELATED (MSR) co-factor from Arabidopsis thaliana.

conclusionThe results provide novel routes for the engineering of polysaccharide-based biomaterials that are needed for a sustainable bioeconomy. The characterization of chimeric cellulose synthase-like enzymes in yeast offers an exciting avenue to produce plant polysaccharides in a tunable manner. Furthermore, cells modified with non-toxic plant polysaccharides such as β-mannan offer a modular chassis to produce and encapsulate sensitive cargo such as therapeutic proteins.

Indexed as

Cell wall biosynthesisChimeric enzymesGlucanGlucomannanGlycosyltransferaseHemicelluloseMannanPichia pastorisSynthetic biology

Identifiers

PMID34147122
PMCPMC8214268
OpenAlexW3175716856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.